华润医药：截至二零二五年六月三十日止六个月之中期业绩公告

3320 — — 5,053,6375,540,556 — 1. 2641 2. 2.1. 34 2.2 34 2410 622436 662(3)63 406(2)407(2)(3) 2.2. 21— 3. (a)—(b)—(c)—(d)— 4. 5. 6. 7. 8. * 9. 10. 6,282,510,4616,282,510,461 11. (a) 0.072452521 (b) —0.052—0.154 0.052327 12. 1,225,102,000877,205,000 19,926,00057,709,000606,0001,694,000 13. a: b: 03031606190911801813651 0303160619091180 a: b: 30903018016,484,375,00017,581,278,000387,490,000330,791,0005,223,557,0005,254,027,000 0303160619090 GDP5.3% 12,275.21.2%1,766.92.8% 203020253AI DRG/DIP 2025(BII)29500 1. 131,866.8128,597.62.5%16.6%79.2%4.2% 21,509.620,933.52.8%16.3% 5,053.65,540.68.8%2,077.32,604.820.3%1.3%4.7%0.330.410.0720.083 2. (1) 24,808.34.3%59.3%0.8 83561944555235 13,062.09.1%8.6%76.5%8,928.36.0%5.0%6.7%3.2%1,269.611.9%1,548.429.9% (2) a. 7771381 102.4551.23 (ADHD)HiCM–188iPSCHiCM–188 b. 12.547617824151103,86842.0% 50110%(II)1910ml:1.0gB648 1712 DRIPs5,400RAISe+ c. 1,500GAP3207.2% 22(QMS)(LIMS) 141WMS/OMS 100% d. 15(TheGlobal Fund)137 5020% 3. (1) 108,329.72.3%5.9% 5,514.611.4%(DTP)DTP37.614.1%6.1%0.4DTP (2) 2822704DTP279187 a. TOP8009 b. 311.86.8 c. 8%IVD711—— d. 10COECOEAI1,500200++ e. DTP8218 4. SCRM43202522025 BC85% 5. 24.14342,500ESGMSCI-ESGABBABBBESG ++ AI 17,673.916,424.7 100%100%75.4%70.5% 1.411.41 57.2%52.3% 1,531.01,019.95,017.33,460.54,731.22,115.9 71,415.160,568.52,987.61,997.54.2%3.3% 1,553.11,526.7 86,000 0.0720.0831.01.09570.07891617 (i)(ii) 1617 C1 C.2.1C.2.1 C.3.3 F.2.2F.1.3 C3 2410 (www.hkexnews.hk)(www.crpharm.com)